News Cosmetics Microbiology
GSK Parma (Italy) manufacturing site receives FDA approval to use Scan RDI system
GlaxoSmithKline (GSK) Parma (Italy) manufacturing site receives FDA inspection and formal approval to use AES CHEMUNEX’s ChemScan RDI system as a part of a rapid microbiological in-process monitoring of a non sterile nasal spray product eliminating the need for end product microbial testing prior to release.
